NASDAQ Biotechnology Total Retu XNBI Indice
4453.6 USD
{{ price }}
1.677827%
{{change_pct}}%
PAESE
stati Uniti
Borsa valori
Nasdaq GIDS
MIN - MAX [24 ore]
4437.49
-
4530.28 USD
Numero di componenti
190
NASDAQ Biotechnology Total Retu Grafico dei prezzi
Top 5 Vincitori delle Ultime 24 Ore
| NVAX | Novavax | +19.52% | |
|---|---|---|---|
| MCRB | Seres Therapeutics | +19.24% | |
| EGRX | Eagle Pharmaceuticals | +12.57% | |
| MGNX | MacroGenics | +12.5% | |
| RGLS | Regulus Therapeutics | +9.91% |
Top 5 Perdenti delle Ultime 24 Ore
| NSTG | NanoString | -37.43% | |
|---|---|---|---|
| TRVN | Trevena | -7.2% | |
| BLUE | bluebird bio | -5.76% | |
| DRRX | DURECT | -4.46% | |
| COLL | Collegium Pharmaceutical | -3.35% |
NASDAQ Biotechnology Total Retu XNBI PANORAMICA FINANZIARIA E DI TRADING
| NASDAQ Biotechnology Total Retu Prezzo dell'Indice | 4453.6 USD |
| Chiusura Precedente | 4472.96 USD |
| Apertura | 4476.26 USD |
| Prezzo di Acquisto | 0 USD x 0 |
| Prezzo di Vendita | 0 USD x 0 |
| Variazione Giornaliera | 4464.53 - 4532.84 USD |
| Variazione a 52 Settimane | 4464.53 - 4532.84 USD |
| Volume | 0 USD |
| Volume Medio | N/A |
Informazioni di trading
NASDAQ Biotechnology Total Retu Storico dei prezzi dell'Indice
| Massimo a 52 Settimane | 4532.84 USD |
| Minimo a 52 Settimane | 4464.53 USD |
| Media Mobile a 50 Giorni | N/A |
| Media Mobile a 200 Giorni | N/A |
XNBI Statistiche dell'indice
| Volume Medio (3 Mesi) | N/A |
| Vol. Medio Giornaliero (10 Giorni) | N/A |
D&R per l'Indice NASDAQ Biotechnology Total Retu
Qual è il prezzo attuale dell'Indice XNBI?
Il prezzo dell'Indice NASDAQ Biotechnology Total Retu XNBI oggi è di 4453.6 USD.
Come acquistare l'Indice NASDAQ Biotechnology Total Retu?
Puoi acquistare l'indice XNBI sulla borsa Nasdaq GIDS. Contatta il tuo consulente finanziario per selezionare un broker.
Qual è la sigla borsistica dell'Indice NASDAQ Biotechnology Total Retu?
La sigla (o ticker) dell'Indice NASDAQ Biotechnology Total Retu è XNBI.
Quanti componenti contiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu contiene 190 componenti.
A quale paese appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento a United States.
A quale borsa appartiene l'Indice NASDAQ Biotechnology Total Retu?
L'Indice NASDAQ Biotechnology Total Retu fa riferimento alla borsa Nasdaq GIDS.
NASDAQ Biotechnology Total Retu COMPONENTI
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|
| Nome Nome | Prezzo Prezzo |
24o% 7g grafico 24o% & 7g |
Cap. Mercato Cap. di mercato | VOL Volume | Min 24h | Max 24h | Cap. di mercato | Rapporto P/E | EPS |
|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
| Amgen AMGN | $277.9 — |
-0.18
|
$149.41B — | $2.68M — | $276.42 — | $283.6 — | $149.41B — | 36.75 | $7.56 — |
| Gilead Sciences GILD | $106.38 — |
+0.82
|
$132.62B — | $7.72M — | $99.32 — | $106.64 — | $132.62B — | 279.94 | $0.38 — |
| Vertex Pharmaceuticals Incorporated VRTX | $492.42 — |
+0.4
|
$126.59B — | $1.24M — | $484.97 — | $498.41 — | $126.59B — | 0 | -$2.07 — |
| Regeneron Pharmaceuticals REGN | $587.85 — |
+0.4
|
$64.27B — | $730.92K — | $584.45 — | $603.77 — | $64.27B — | 15.33 | $38.33 — |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — |
| Alnylam Pharmaceuticals ALNY | $241.97 — |
+2.2
|
$31.32B — | $752.7K — | $240.02 — | $248 — | $31.32B — | 0 | -$2.18 — |
| Biogen BIIB | $118.17 — |
-0.61
|
$17.3B — | $2.02M — | $117.21 — | $121.75 — | $17.3B — | 10.56 | $11.18 — |
| United Therapeutics UTHR | $293.46 — |
+0.22
|
$13.18B — | $208.41K — | $291.93 — | $298.3 — | $13.18B — | 11.90 | $24.65 — |
| Insmed Incorporated INSM | $70.8 — |
-0.62
|
$12.87B — | $1.45M — | $70.63 — | $72.71 — | $12.87B — | 0 | -$5.57 — |
| Illumina ILMN | $76.25 — |
+2.56
|
$12.07B — | $1.66M — | $75.34 — | $79.37 — | $12.07B — | 0 | -$7.69 — |
| BioMarin Pharmaceutical BMRN | $61.94 — |
+0.72
|
$11.88B — | $1.26M — | $61.63 — | $63.39 — | $11.88B — | 28.02 | $2.21 — |
| Incyte INCY | $58 — |
+1.08
|
$11.22B — | $1.72M — | $57.65 — | $59.01 — | $11.22B — | 386.66 | $0.15 — |
| Neurocrine Biosciences NBIX | $103.22 — |
+1.45
|
$10.21B — | $1.92M — | $102.43 — | $106.2 — | $10.21B — | 31.37 | $3.29 — |
| Exelixis EXEL | $36.78 — |
+0.82
|
$10.14B — | $2.62M — | $36.56 — | $37.67 — | $10.14B — | 20.89 | $1.76 — |
| Qiagen QGEN | $42.32 — |
-0.05
|
$9.15B — | $1.37M — | $42.2 — | $43 — | $9.15B — | 111.36 | $0.38 — |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — |
| Repligen RGEN | $141.4 — |
+1.78
|
$7.94B — | $608.02K — | $140.7 — | $148.94 — | $7.94B — | 0 | -$0.47 — |
| Bio-Techne TECH | $50.16 — |
+2.2
|
$7.93B — | $1.71M — | $50.03 — | $53.54 — | $7.93B — | 51.18 | $0.98 — |
| Halozyme Therapeutics HALO | $58.41 — |
+0.34
|
$7.22B — | $1.41M — | $57.66 — | $59.23 — | $7.22B — | 17.02 | $3.43 — |
| Jazz Pharmaceuticals JAZZ | $104.19 — |
+0.78
|
$6.33B — | $809.04K — | $103.76 — | $106.77 — | $6.33B — | 12.04 | $8.65 — |
- {{ link.label }} {{link}}